European regulators urge doctors to limit the use of Xeljanz and similar drugs among certain patients more prone to heart problems and blood clots.
Drugs like Humira and Remicade, designed to treat autoimmune disorders, may increase the risk of new onset psoriasis, according to the findings of a new study.
A new study raises doubts about whether Xeljanz and similar drugs increase the risk of blood clots.
Xeljanz use carries a higher infection risk than other arthritis drugs, like Humira, according to the findings of a new study.
A new study links Xeljanz and similar drugs to an increased risk of skin cancer.
A Xeljanz stroke lawsuit claims Pfizer failed to adequately warn about the drug's heart risks.
A new study links air pollution exposure to an increased risk of autoimmune disorders such as rheumatoid arthritis and inflammatory bowel disease.
Mallinckrodt will pay $260 million to resolve illegal Medicaid fraud and kickback claims brought against it by whistleblowers and the federal government over its marketing of Acthar gel.
A Xeljanz lawsuit claims Pfizer misled the public about the safety of the rheumatoid arthritis drug, leading to a man suffering a life-threatening blood clot.
A request for approval for Olumiant to treat lupus has been withdrawn, and the manufacturers expect the FDA to reject an atopic dermatitis approval request in the face of growing…
